Buyukunal E - Search Results

1

Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase III 'Stop and Go' study results--a Turkish Oncology Group Trial.

Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S, Ozdener F, Cevik D. Yalcin S, et al. Among authors: buyukunal e. Oncology. 2013;85(6):328-35. doi: 10.1159/000355914. Epub 2013 Nov 12. Oncology. 2013. PMID: 24247559 Free article. Clinical Trial.

2

The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.

Selcukbiricik F, Erdamar S, Ozkurt CU, Molinas Mandel N, Demirelli F, Ozguroglu M, Tural D, Buyukunal E, Serdengecti S. Selcukbiricik F, et al. Among authors: buyukunal e. J BUON. 2013 Jan-Mar;18(1):116-23. J BUON. 2013. PMID: 23613396 Free article.

3

Neoadjuvant chemotherapy in locally advanced breast cancer: a preliminary report. Turkish Oncology Study Group.

Baltali E, Günel N, Onat DA, Atahan IL, Akçali Z, Büyükünal E, Firat D. Baltali E, et al. Among authors: buyukunal e. Tumori. 1999 Nov-Dec;85(6):483-7. doi: 10.1177/030089169908500611. Tumori. 1999. PMID: 10774570

4

What is the optimal treatment in clinical stage T3N0M0 rectal cancer?

Tural D, Yildiz O, Elcin O, Erdamar S, Guney S, Demireli F, Buyukunal E, Serdengecti S. Tural D, et al. Among authors: buyukunal e. J BUON. 2014 Jan-Mar;19(1):97-102. J BUON. 2014. PMID: 24659649 Free article.

5

Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?

Ozturk MA, Dane F, Karagoz S, Tural D, Selcukbiricik F, Demirelli F, Buyukunal E, Ozguroglu M, Turna H, Erdamar S, Celikel CA, Bozkurtlar EB, Yumuk PF, Mandel NM, Turhal NS, Serdengecti S. Ozturk MA, et al. Among authors: buyukunal e. Hepatogastroenterology. 2015 Jan-Feb;62(137):59-64. Hepatogastroenterology. 2015. PMID: 25911868

6

A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.

Tural D, Selçukbiricik F, Serdengeçti S, Büyükünal E. Tural D, et al. Among authors: buyukunal e. World J Surg Oncol. 2012 Nov 2;10:234. doi: 10.1186/1477-7819-10-234. World J Surg Oncol. 2012. PMID: 23121731 Free PMC article.

7

Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.

Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S. Tural D, et al. Among authors: buyukunal e. Int J Clin Oncol. 2014 Oct;19(5):889-96. doi: 10.1007/s10147-013-0636-4. Epub 2013 Nov 12. Int J Clin Oncol. 2014. PMID: 24218281

8

Male breast cancers behave differently in elderly patients.

Tural D, Selçukbiricik F, Aydoğan F, Beşe N, Yetmen O, Ilvan Ş, Büyükünal E, Serdengeçti S. Tural D, et al. Among authors: buyukunal e. Jpn J Clin Oncol. 2013 Jan;43(1):22-7. doi: 10.1093/jjco/hys193. Epub 2012 Nov 15. Jpn J Clin Oncol. 2013. PMID: 23159765

9

Serum erythropoietin level in anemic cancer patients.

Ozguroglu M, Arun B, Demir G, Demirelli F, Mandel NM, Buyukunal E, Serdengecti S, Berkarda B. Ozguroglu M, et al. Among authors: buyukunal e. Med Oncol. 2000 Feb;17(1):29-34. doi: 10.1007/BF02826213. Med Oncol. 2000. PMID: 10713657

10

Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?

Selcukbiricik F, Bilici A, Tural D, Erdamar S, Soyluk O, Buyukunal E, Demirelli F, Serdengecti S. Selcukbiricik F, et al. Among authors: buyukunal e. Tumour Biol. 2013 Aug;34(4):2233-9. doi: 10.1007/s13277-013-0763-6. Epub 2013 Apr 28. Tumour Biol. 2013. PMID: 23625655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters